Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16367106 | 0.85 | KDM4E (0.31) | KDM4EALDH1A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL16770363 | 0.73 | PSMD14 (0.34) | PSMD14 | |
| SCHEMBL2376039 | 0.71 | HSD17B10 (0.39) | KDM4EALDH1A1CYP3A4 | |
| SCHEMBL24099494 | 0.70 | KDM4E (0.30) | KDM4E | |
| SCHEMBL807055 | 0.70 | KDM4E (0.34) | KDM4EALDH1A1CYP3A4 | |
| SCHEMBL29717170 | 0.70 | KDM4E (0.47) | KDM4EALDH1A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL16500668 | 0.70 | KDM4E (0.47) | KDM4EALDH1A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL18500848 | 0.70 | KDM4E (0.32) | KDM4E | |
| SCHEMBL6466586 | 0.70 | KDM4E (0.47) | KDM4EALDH1A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL17536132 | 0.70 | HSD17B10 (0.38) | KDM4EALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10174145-B1 | Methacrylic resin | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2019-01-08 | — | — | US | disclosed |
| US-10030134-B2 | Acrylic thermoplastic resin composition and molded article thereof | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2018-07-24 | — | — | US | disclosed |
| US-20180057677-A1 | METHACRYLIC RESIN COMPOSITION AND OPTICAL COMPONENT | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2018-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180057677-A1 | METHACRYLIC RESIN COMPOSITION AND OPTICAL COMPONENT | SDC1, SUGT1, MACF1 | KDM4E 1984/4885ALDH1A1 761/4885CYP3A4 1437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.